Glucosamine Chondroitin & MSM (500/400/250) Tablet
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Chlorhydrate de glucosamine | 500 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtin sulfate de sodium | 400 milligramme | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 250 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Acide stéarique, Maltodextrine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis of the knee. Helps to maintain healthy cartilage. Helps to relieve joint pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner.
- Effets indésirables connus
Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
Product record
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80069604
- Status
- Inactive licence
- Licence date
- 24 May 2016
- Revision date
- 18 May 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80069604
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Glucosamine Chondroitin & MSM (500/400/250) Tablet (BIOVANTEK): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80069604-glucosamine-chondroitin-msm-500-400-250-tablet, updated 18 May 2022.